This is a competitive revision in response to NOT-OD-09-058, the ARRA call for Competitive Supplement Applications. In the past decade there has been a growing awareness of the disabling effects of impaired cognition in individuals with schizophrenia and the importance of developing new treatments that target cognitive deficits. During this same period, the cognitive neuroscience field has seen an explosion of new knowledge regarding the neural basis of cognition. The application of this new knowledge to drug development in schizophrenia has lagged significantly behind overall progress in cognitive neuroscience, in large part due to the lack of data on the measurement properties of tasks used in cognitive neuroscience. This concern led to the Cognitive Neuroscience Research To Improve Cognition in Schizophrenia (CNTRICS) initiative, which conducted a series of conferences designed to develop consensus on the constructs and paradigms from cognitive neuroscience that are ripe for translation for use in clinical trials contexts. We were recently funded to start this translation process (Cognitive Neuroscience Task Reliability &Clinical Applications (CNTRACs) Consortium."""""""") for behavioral paradigms. We brought together a collaborative team that represents significant expertise from the many fields necessary for the success of this endeavor. We are focusing on four constructs that span both early (gain control and visual integration in perception) and higher-level (goal maintenance, relational encoding and retrieval) components of human cognitive processing. Is this competitive revision we will extend this work in a highly critical and significant direction that the field has identified as a growing need - the development of well validated, and reliable functional neuroimaging paradigms that can serve as biomarkers for predicting and assessing drug and intervention response to treatments designed to enhance cognition. This focus meets one of the key topic areas for Competitive Supplements identified by the NIMH, namely Biomaterials and Biological Measures for the Study of Mental Disorders, which includes """"""""Systematically collecting and analyzing biological measures (e.g., genetic polymorphisms, brain imaging indexes), which could be used, also in combination with clinically derived variables, to identify predictors of outcome, moderators of treatment response and adverse effects, or mediators and patterns of treatment effects."""""""" The end goal for these expanded aims will be to provide the field with: 1) easy to use imaging paradigms of these three cognitive functions that: 2) have been optimized for use in a clinical trials context (efficient, reliable, robust);while 3) maintaining their validity as specific measures of the cognitive and neural processes of interest. We believe that it is feasible to complete this added Aim in the time frame of the ARRA announcement, given that we have an established infrastructure. This set of collaborative R01 proposals meet the goals of the ARRA stimulus by providing for funding for 9 new positions, 3 positions that would allow us to retain staff that would otherwise need to be let go, and 1 position that we can increase from part to full time.

Public Health Relevance

This project has high relevance for public health by significantly improving our ability to translate paradigms developed into the basic cognitive neuroscience literature for use in clinical trials aimed at improving cognition in schizophrenia. Cognitive deficits in schizophrenia are a major predictor of functional outcome in this debilitating illness. Thus, we need to improve our methods for detecting and enhancing cognitive function in schizophrenia in order to help individuals with this illness lead more productive and fulfilling lives.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
3R01MH084826-03S1
Application #
7810857
Study Section
Special Emphasis Panel (ZMH1-ERB-Z (A1))
Program Officer
Kozak, Michael J
Project Start
2010-07-01
Project End
2012-06-30
Budget Start
2010-07-01
Budget End
2012-06-30
Support Year
3
Fiscal Year
2010
Total Cost
$261,061
Indirect Cost
Name
University of California Davis
Department
Psychiatry
Type
Schools of Medicine
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Guo, J Y; Ragland, J D; Carter, C S (2018) Memory and cognition in schizophrenia. Mol Psychiatry :
Barch, Deanna M; Carter, Cameron S; Gold, James M et al. (2017) Explicit and implicit reinforcement learning across the psychosis spectrum. J Abnorm Psychol 126:694-711
Poppe, Andrew B; Barch, Deanna M; Carter, Cameron S et al. (2016) Reduced Frontoparietal Activity in Schizophrenia Is Linked to a Specific Deficit in Goal Maintenance: A Multisite Functional Imaging Study. Schizophr Bull 42:1149-57
Lopez-Garcia, Pilar; Lesh, Tyler A; Salo, Taylor et al. (2016) The neural circuitry supporting goal maintenance during cognitive control: a comparison of expectancy AX-CPT and dot probe expectancy paradigms. Cogn Affect Behav Neurosci 16:164-75
Silverstein, Steven M; Harms, Michael P; Carter, Cameron S et al. (2015) Cortical contributions to impaired contour integration in schizophrenia. Neuropsychologia 75:469-80
Ragland, J Daniel; Ranganath, Charan; Harms, Michael P et al. (2015) Functional and Neuroanatomic Specificity of Episodic Memory Dysfunction in Schizophrenia: A Functional Magnetic Resonance Imaging Study of the Relational and Item-Specific Encoding Task. JAMA Psychiatry 72:909-16
Strauss, Milton E; McLouth, Christopher J; Barch, Deanna M et al. (2014) Temporal stability and moderating effects of age and sex on CNTRaCS task performance. Schizophr Bull 40:835-44
Sheffield, Julia M; Gold, James M; Strauss, Milton E et al. (2014) Common and specific cognitive deficits in schizophrenia: relationships to function. Cogn Affect Behav Neurosci 14:161-74
Owoso, A; Carter, C S; Gold, J M et al. (2013) Cognition in schizophrenia and schizo-affective disorder: impairments that are more similar than different. Psychol Med 43:2535-45
Poppe, Andrew B; Wisner, Krista; Atluri, Gowtham et al. (2013) Toward a neurometric foundation for probabilistic independent component analysis of fMRI data. Cogn Affect Behav Neurosci 13:641-59

Showing the most recent 10 out of 15 publications